Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars announced.

Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan ...

This floor price is at a premium to the stock's recent performance. On Monday, shares of Biocon settled 2 per cent lower at Rs 372.05 on the BSE.

Biocon QIP Floor Price: Pharmaceuticals company Biocon Ltd, a constituent of BSE 200 index, has announced the opening of its qualified institutions placement (QIP). Biocon, through an exchange filing ...

Biocon Ltd said it had concluded a Qualified Institutions Placement, raising Rs 4,150 crore through the issuance of equity shares to eligible qualified institutional buyers. The Bengaluru-based ...